Content by Zyme Communications Ltd.

Agreement gives BIA Separations access to proprietary technology to better preserve integrity, infectivity and potency of immunoaffinity-purified viral vectors for gene therapy

Unique kit enables the fast and easy development of customized sandwich lateral flow assays

Sphere Fluidics approached TTP to address the challenges associated with the development of a highly complex laboratory instrument and microfluidic cartridge. 

Leader in artificial intelligence for CRISPR genome editing technology seeks funding to build on successful research programmes and commercialise new products

IONTAS will provide Glythera with antibodies from its fully human antibody libraries. Glythera will use these antibodies, in combination with its novel toxin portfolio, to develop next generation ADCs with improved efficacy and safety, to target difficult-to-treat tumours.

Fluorescent kits designed for use with ScreenChip System for automatic screening and phenotyping

Cambridge Epigenetix licenses fundamental DNA methylation IP from Boston Children’s Hospital  

Enables detailed control in thawing of cell and gene therapies

Expanded kit offering strengthens position of Gyrolab automated solution for analysis in bioprocess workflows.